ATE390921T1 - Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung - Google Patents

Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung

Info

Publication number
ATE390921T1
ATE390921T1 AT01951327T AT01951327T ATE390921T1 AT E390921 T1 ATE390921 T1 AT E390921T1 AT 01951327 T AT01951327 T AT 01951327T AT 01951327 T AT01951327 T AT 01951327T AT E390921 T1 ATE390921 T1 AT E390921T1
Authority
AT
Austria
Prior art keywords
platinum
combination
containing anticancer
anticancer agents
demethylcantharidine
Prior art date
Application number
AT01951327T
Other languages
English (en)
Inventor
Steve C F Au-Yeung
Kenneth K W To
Yee-Ping Ho
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Application granted granted Critical
Publication of ATE390921T1 publication Critical patent/ATE390921T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
AT01951327T 2001-05-31 2001-05-31 Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung ATE390921T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000885 WO2002096413A1 (en) 2001-05-31 2001-05-31 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof

Publications (1)

Publication Number Publication Date
ATE390921T1 true ATE390921T1 (de) 2008-04-15

Family

ID=4574808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951327T ATE390921T1 (de) 2001-05-31 2001-05-31 Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung

Country Status (7)

Country Link
US (1) US20040152766A1 (de)
EP (1) EP1390027B1 (de)
JP (1) JP2004532260A (de)
CN (1) CN1237065C (de)
AT (1) ATE390921T1 (de)
DE (1) DE60133491D1 (de)
WO (1) WO2002096413A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087630A1 (en) * 2003-03-28 2004-10-14 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
CN1680384A (zh) * 2004-04-08 2005-10-12 香港中文大学 去甲基斑蟊素铂配合物及其用途
CA2971279C (en) * 2014-12-17 2023-09-19 Matthew Davidson Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
BR112017027277A2 (pt) 2015-06-19 2018-09-04 Syn Nat Products Entpr Llc ?método para o tratamento ou prevenção de uma doença e métodos para matar uma célula?
AU2018281313B2 (en) 2017-06-06 2024-05-02 Verrica Pharmaceuticals Inc. Treatment of cutaneous disorders
EP3638356A1 (de) 2017-06-15 2020-04-22 Verrica Pharmaceuticals, Inc. Vorrichtungen und verfahren zur behandlung von erkrankungen der körperoberfläche
USD900312S1 (en) 2017-06-15 2020-10-27 Verrica Pharmaceuticals, Inc. Applicator
KR102765631B1 (ko) 2017-10-04 2025-02-11 베리카 파마슈티컬스 인크. 칸타리딘의 합성

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068002C (zh) * 1997-04-30 2001-07-04 中国科学院大连化学物理研究所 铂抗癌药物及合成
AUPP466598A0 (en) * 1998-07-14 1998-08-06 University Of Newcastle Research Associates Limited, The Product and process

Also Published As

Publication number Publication date
JP2004532260A (ja) 2004-10-21
WO2002096413A1 (en) 2002-12-05
EP1390027A4 (de) 2004-06-30
DE60133491D1 (de) 2008-05-15
EP1390027B1 (de) 2008-04-02
EP1390027A1 (de) 2004-02-25
CN1499966A (zh) 2004-05-26
HK1064955A1 (en) 2005-02-08
US20040152766A1 (en) 2004-08-05
CN1237065C (zh) 2006-01-18

Similar Documents

Publication Publication Date Title
ATE350409T1 (de) Ampholytisches copolymer und dessen verwendung
ATE538103T1 (de) Chinazolinonverbindungen als antikrebsmittel
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
SI1742644T1 (sl) Terapevtski sestavek ki vsebuje vsaj en derivat pirolobenzodiazepina in fludarabin
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
TR200100054T2 (tr) Paroksetin metansülfonat
MXPA05008478A (es) Heterociclos sustituidos.
WO2002102306A3 (en) Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
DE60209721D1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
GEP20094801B (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
ATE390921T1 (de) Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
IL178727A0 (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
HUP0203153A2 (hu) Kombinációs kemoterápia
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
EP1558282A4 (de) Zusammensetzungen gegen krebs und infektionskrankheiten und anwendungsverfahren dafür
IL147890A0 (en) Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
MXPA01009032A (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso se la produccion de il-12.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties